SeaStar Medical
ICU
50 hedge funds and large institutions have $92.2M invested in SeaStar Medical in 2022 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 5 increasing their positions, 8 reducing their positions, and 1 closing their positions.
600% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 1
14% more funds holding
Funds holding: 44 → 50 (+6)
2% more capital invested
Capital invested by funds: $90.2M → $92.2M (+$2.01M)
0.02% more ownership
Funds ownership: 0.34% → 0.36% (+0.02%)
38% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Shaolin Capital Management
Miami,
Florida
|
+$3.05M |
| 2 |
Janus Henderson Group
London,
United Kingdom
|
+$981K |
| 3 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
+$780K |
| 4 |
CC
Centiva Capital
New York
|
+$699K |
| 5 |
D.E. Shaw & Co
New York
|
+$403K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$772K |
| 2 |
KIM
Karpus Investment Management
Pittsford,
New York
|
-$632K |
| 3 |
KKRC
Kohlberg Kravis Roberts & Co
New York
|
-$304K |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
-$161K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$56K |
ICU Hedge Fund Activity: Q1 2022 in Review
50 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in SeaStar Medical (ICU) for Q1 2022, worth a combined $92.2M — up 2.2% from $90.2M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new ICU positions and 1 closed out — a net gain of 6 holders — while 5 added to existing stakes and 8 trimmed.
The largest buyer was Shaolin Capital Management, opening a new position worth an estimated $3.05M. The largest seller was Millennium Management, cutting an estimated $772K.
- 50 institutional investors held SeaStar Medical (ICU) as of Q1 2022, up from 44 in Q4 2021.
- Funds reported $92.2M of SeaStar Medical stock for Q1 2022, up 2.2% quarter-over-quarter.
- 7 funds opened new SeaStar Medical positions in Q1 2022 and 1 closed out, a net change of +6 holders.
- The largest SeaStar Medical buyer in Q1 2022 was Shaolin Capital Management, an estimated $3.05M added.
- The largest SeaStar Medical seller in Q1 2022 was Millennium Management, an estimated $772K sold.
Based on aggregated 13F filings for Q1 2022.